Patent Assignment
Reel/Frame 045384/0278
Merger
Recorded: 2018-02-20
Pages: 3
Assignor
PROTIVA BIOTHERAPEUTICS INC.
Executed: 2018-01-01
Assignee
ARBUTUS BIOPHARMA CORPORATION
25TH FLOOR, 700 WEST GEORGIA STREET, VANCOUVER, BC, V7Y 1B3, CANADA
Covered Properties
(36)
Sensitizing Cells to Compounds Using Lipid-Mediated Gene and Compound Delivery
Patent:
6,410,328 →
Application:
09/243,104 →
Combination Therapy Using Nucleic Acids and Conventional Drugs
Patent:
6,841,537 →
Application:
09/295,663 →
Combination Therapy Using Nucleic Acids and Radio Therapy
Patent:
6,841,538 →
Application:
09/295,925 →
Liposomal Apparatus and Manufacturing Methods
Polyethyleneglycol-Modified Lipid Compounds and Uses Thereof
Lipid Encapsulated Interfering Rna
Cationic Lipids and Methods of Use
Compositions Comprising Immunostimulatory Sirna Molecules and Dlindma or Dlendma
Lipid Encapsulated Interfering Rna
Systems and Methods for Manufacturing Liposomes
Sirna Silencing of Filovirus Gene Expression
Modified Sirna Molecules and Uses Thereof
Modified Sirna Molecules and Uses Thereof
Silencing of Polo-Like Kinase Expression Using Interfering Rna
Modified Sirna Molecules and Uses Thereof
Novel Lipid Formulations for Nucleic Acid Delivery
Cationic Lipids and Methods of Use
Application:
12/796,573 →
Publication:
US 2011/0262527
Lipid Formulations for Nucleic Acid Delivery
Compositions and Methods for Silencing Apolipoprotein B
Lipid Encapsulating Interfering Rna
Silencing of CSN5 Gene Expression Using Interfering Rna
Liposomal Apparatus and Manufacturing Method
Compositions and Methods for Silencing Genes Involved in Hemorrhagic Fever
Patent:
8,455,455 →
Application:
13/077,856 →
Modified Sirna Molecules and Uses Thereof
Compositions and Methods for Silencing Genes Expressed in Cancer
Liposomal Apparatus and Manufacturing Methods
Non-Liposomal Systems for Nucleic Acid Delivery
Novel Lipid Formulations for Nucleic Acid Delivery
Modified Sirna Molecules and Uses Thereof
Lipid Compositions for Nucleic Acid Delivery
Novel Lipid Formulations for Delivery of Therapeutic Agents to Solid Tumors
Non-Liposomal Systems for Nucleic Acid Delivery
Lipid Encapsulating Interfering Rna
Non-Liposomal Systems for Nucleic Acid Delivery
Liposomal Apparatus and Manufacturing Methods
Application:
15/299,413 →
Publication:
US 2017/0258719
Novel Lipid Formulations for Delivery of Therapeutic Agents to Solid Tumors
Application:
15/818,064 →
Publication:
US 2018/0071397
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 29, 2004
From: MACLACHLAN, IAN; JEFFS, LLOYD; PALMER, LORNE R.
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 015220/0516 →
Assignment of Assignor's Interest
Jul 6, 2004
From: NOELLE GIESBRECHT, LEGAL REPRESENTATIVE FOR CORY GIESBRECHT (DECEASED)
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 014821/0744 →
Assignment of Assignor's Interest
Apr 12, 2005
From: HEYES, JAMES; MACLACHLAN, IAN; AMBEGIA, ELLEN GRACE
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 016057/0993 →
Assignment of Assignor's Interest
Aug 30, 2005
From: MACLACHLAN, IAN; PALMER, LORNE R.; HEYES, JAMES
To: PROTIVIA BIOTHERAPEUTICS, INC.
Reel/Frame 016471/0770 →
Assignment of Assignor's Interest
Oct 17, 2005
From: MACLACHLAN, IAN; JUDGE, ADAM
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 016648/0159 →
Assignment of Assignor's Interest
Dec 21, 2005
From: HEYES, JAMES; MACLACHLAN, IAN; PALMER, LORNE R.
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 017137/0926 →
Assignment of Assignor's Interest
Nov 17, 2006
From: MACLACHLAN, IAN; JEFFS, LLOYD B.; YAWORSKI, EDWARD; LAM, KIEU
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 018533/0451 →
Assignment of Assignor's Interest
Feb 5, 2007
From: MACLACHLAN, IAN; JUDGE, ADAM
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 018851/0262 →
Assignment of Assignor's Interest
Feb 28, 2008
From: MACLACHLAN, IAN; JUDGE, ADAM
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 020578/0206 →
Assignment of Assignor's Interest
May 8, 2009
From: MACLACHLAN, IAN; JUDGE, ADAM
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 022658/0518 →
Assignment of Assignor's Interest
Dec 9, 2009
From: MACLACHLAN, IAN; YAWORSKI, EDWARD; LAM, KIEU
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 023628/0829 →
Assignment of Assignor's Interest
Dec 9, 2009
From: JEFFS, LLOYD; PALMER, LORNE
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 023628/0944 →
Assignment of Assignor's Interest
Feb 9, 2010
From: HEYES, JAMES; PALMER, LORNE
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 023916/0712 →
Assignment of Assignor's Interest
Jul 14, 2010
From: MACLACHLAN, IAN; SOOD, VANDANA
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 024685/0650 →
Assignment of Assignor's Interest
Jun 10, 2011
From: MACLACHLAN, IAN; AMBEGIA, ELLEN GRACE; HEYES, JAMES
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 026429/0205 →
Security Agreement
Dec 29, 2011
From: PROTIVA BIOTHERAPEUTICS, INC.
To: SILICON VALLEY BANK
Reel/Frame 027463/0613 →
Assignment of Assignor's Interest
Mar 23, 2012
From: MACLACHLAN, IAN; JUDGE, ADAM
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 027919/0092 →
Assignment of Assignor's Interest
Apr 11, 2012
From: LEE, AMY C.H.; SOOD, VANDANA
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 028030/0301 →
Assignment of Assignor's Interest
Apr 18, 2012
From: YAWORSKI, ED; REID, STEPHEN; HEYES, JAMES; JUDGE, ADAM
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 028068/0966 →
Assignment of Assignor's Interest
Aug 10, 2017
From: HEYES, JAMES; MACLACHLAN, IAN; PALMER, LORNE R.
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 043263/0424 →
Release of Security Interest
Feb 16, 2023
From: SILICON VALLEY BANK
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 062721/0199 →